Reduced lung fluid club cell secretory protein informs chronic lung allograft dysfunction risk

By afschroeder • November 28, 2025

Rim JG, Weber JM, Neely ML, O'Grady N, Kelly FL, Myers RA, Nagler A, McArthur P, Frankel CW, Belperio JA, Budev M, Hartwig MG, Martinu T, Reynolds JM, Shah PD, Singer LG, Snyder LD, Weigt SS, Palmer SM, Todd JL. Reduced lung fluid club cell secretory protein informs chronic lung allograft dysfunction risk. Eur Respir J. 2025 Nov 27:2500182. doi: 10.1183/13993003.00182-2025. Epub ahead of print. PMID: 41309269.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Epcoritamab plus rituximab, dexamethasone, cytarabine, oxaliplatin/carboplatin induces deep and durable responses in transplant-eligible patients with relapsed or refractory diffuse large B-cell lymphoma: results from the EPCORE NHL-2 trial

Abrisqueta P, Karimi YH, Morillo D, Cordoba R, Phillips T, De Vos S, Nijland M, Offner F, Andersson PO, Brody J, Cheah CY, Prieto PG,[...]

Neoadjuvant BO-112 and hypofractionated radiation therapy with or without nivolumab in soft tissue sarcoma: preclinical and phase 1 results

Deng J, Pal A, Testa S, Xu JW, Tran LM, Graham DS, Hargil A, Subramanian A, Campbell KM, Limsuwannarot S, Chumpitaz Lavalle Á, Chin SC,[...]

Peak Oxygen Uptake Prediction From Resting and Submaximal Variables of Cardiopulmonary Exercise Testing

Lee Y, Feng J, Rahrooh A, Bui AAT, Cooper CB, Hsu JJ. Peak Oxygen Uptake Prediction From Resting and Submaximal Variables of Cardiopulmonary Exercise Testing.[...]